CHA
FENC icon

Carmichael Hill & Associates’s Fennec Pharmaceuticals FENC Stock Holding History

Carmichael Hill & Associates’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-90
Closed -$1K – 723
2020
Q2 		$1K Buy
+90
New +$669 ﹤0.01% 658

Other funds holding FENC

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Carmichael Hill & Associates's FENC Position: Q3 2020 in Review

Carmichael Hill & Associates sold out of Fennec Pharmaceuticals (FENC) in Q3 2020, closing a stake of 90 shares — an estimated $1K sold.

Carmichael Hill & Associates first reported a position in FENC in Q2 2020 and held it in 1 quarter. The position peaked at $1K in Q2 2020. 55 funds tracked by Wall St. Rank hold FENC as of Q3 2020.

  • Carmichael Hill & Associates reported no remaining Fennec Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Carmichael Hill & Associates sold 90 Fennec Pharmaceuticals shares in Q3 2020, an estimated $1K.
  • Carmichael Hill & Associates first reported a position in Fennec Pharmaceuticals in Q2 2020 and held it in 1 quarter.
  • Carmichael Hill & Associates's Fennec Pharmaceuticals position peaked at $1K in Q2 2020.
  • 55 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q3 2020.

Based on Carmichael Hill & Associates's 13F filing for Q3 2020, filed 12 Nov 2020.